Abbott Cooper PLLC has initiated an investigation on behalf of Estrella Immunopharma, Inc. stockholders to determine if the company's board of directors violated fiduciary duties or engaged in wrongdoing. Estrella's stock trades on Nasdaq under the symbol ESLA. Stockholders interested in their legal rights can contact Abbott Cooper PLLC at no cost, as the firm works on a contingency fee basis. This investigation could lead to legal action if breaches are found, impacting shareholder value and corporate governance.
Geely Auto Group's Zeekr 7GT has achieved a five-star safety rating under the updated 2026 Euro NCAP protocols, highlighting its strong post-crash safety and crash protection. This marks Geely's ninth model to earn the top Euro NCAP rating, reflectin...
Boost Run, Inc. is rated a buy due to strong demand for AI infrastructure and credible revenue guidance of $170-180 million for 2026. This guidance is supported by substantial prepaid contracts and customer deposits, providing good visibility into fu...
Bitcoin has seen less volatility and fewer liquidations in early July compared to June, but demand remains significantly low. Spot ETF inflows have been positive only in the last three days after a long period of net outflows since mid-May. Metrics t...
Offchain Labs introduced a revenue-sharing model where Layer 2 chains built with Arbitrum's technology but settling outside Arbitrum One or Nova share 10% of their net protocol fees with the Arbitrum ecosystem. This includes Robinhood Chain, which pr...
Valhi, Inc. is currently trading at a roughly 36% discount to its net asset value (NAV), with no obvious catalyst expected to close this gap soon. The company faces margin pressures in Q2 due to higher energy costs impacting its chemicals segment, al...
